跳至主要内容
临床试验/ISRCTN18300486
ISRCTN18300486进行中(未招募)Unknown

Magnetic resonance spectroscopy of 2-hydroxyglutarate for the identification of IDH mutations status in glioma

niversity of Edinburgh0 个研究点目标入组 20 人开始时间: 2023年9月22日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Radiological appearances consistent with diffuse glioma or tissue proven diffuse glioma
  • 2. A signed and dated, informed consent must be obtained prior to study participation
  • 3. Adults aged 18 - 75 years
  • 4. WHO performance status 0 – 1
  • 5. Measurable disease in the case of post-surgery subjects

排除标准

  • 1. Participants for whom MRI is contraindicated
  • 2. Patients with tumours in locations that preclude tissue sampling by biopsy or surgical resection.
  • 3. Patients whose co-morbidities or functional status precludes tissue acquisition by biopsy or surgical resection.

研究者

发起方
niversity of Edinburgh

相似试验

on-invasive detection of brain tumour genetic... | 临床试验